doing imaging on a receptor-based level in humans,” Morrison speculated.—Esther Landhuis None
Biotechnology Ltd., the Australian biotech company that sponsored the trial.—Esther Landhuis None
ARF.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2092 Alzheimer's Disease Amyloid
vectors to induce RNA-mediated silencing of cystatin B in the brains of TgCRND8 mice.—Esther Landhuis.
he said.—Esther Landhuis. None http://www.alzforum.org/new/detail.asp?id=1982 Alzheimer's
ADNI2 participants will get ASL as part of their MRI scan.—Esther Landhuis None
stage of clinical trials in the coming year.”—Esther Landhuis None
these possible side effects, Tomita said.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2778
lowering can be achieved by BACE1 inhibition in humans,” the authors write.—Esther Landhuis None
On behalf of the community, the ARF team congratulates this year’s MetLife winners!—Esther Landhuis. None
in the brain in AD and related diseases. For more on that, see Part 3 of this series.—Esther Landhuis.
connectivity curve as an even earlier marker on their left.—Esther Landhuis None
may be too damaged. “The wires might be frayed,” Eldaief said.—Esther Landhuis None
tau isoforms that appear in the brain (see review by Souter and Lee, 2010).—Esther Landhuis.
attention to that interface.”—Esther Landhuis. This concludes a two-part series. See also Part 1. None